Skip to main content
. Author manuscript; available in PMC: 2019 Sep 28.
Published in final edited form as: J Control Release. 2018 Aug 6;286:315–325. doi: 10.1016/j.jconrel.2018.08.010

Figure 4. Pharmacokinetic profile of TFV-DP and FTC-TP in PBMCs.

Figure 4.

Concentrations of TFV-DP (green) and FTC-TP (blue) in PBMCs from three rhesus macaques at the indicated time points analyzed by LC-MS/MS. Data points represent mean ± SEM. Horizontal dotted line represents preventative target concentration for effective PrEP. Vertical dotted line represents day of transcutaneous refilling of NDI implants (day 70). Animals were euthanized on day 83.